1.5 mg of tirzepatide 5mg Tirzepatide Oral | Starts at

Doctors may prescribe it for adults with obesity (a BMI of 30 or higher) or those who are overweight (a BMI of 27 or higher) and have other medical conditions such as diabetes, hypertension, and hypercholesterolemia

BPC-157 : recovery + immune support, performance Description Peptide known for its potential to support healing, tissue repair, and gut health by promoting cellular regeneration and reducing inflammation

Over 29 days of treatment, the peptide inhibited pulmonary artery muscularization (the thickening and stiffening of pulmonary arteries that drives this condition), prevented right heart hypertrophy (the enlargement of the right ventricle that occurs when it has to pump against increased resistance), and significantly decreased mortality

Multiple patients specifically note having minimal or no side effects, which aligns with the broader tirzepatide experience

Enhanced membrane translocation of protein kinase C (i.e., activation) provides a potential mechanism for diacylglyceride-induced insulin resistance, suggesting hepatic diacylglyceride to be a relevant predictor of insulin resistance in NAFLD [72, 73]

Keep a symptom diary when starting supplementation and be particularly alert for signs of allergic reactions